Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Omonge, EO"'
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S75-S78
The introduction in the mid 1990’s of highly active anti-retroviral drugs therapy (HAART) in the treatment of human immunodeficiency virus (HIV) infection has significantly changed the course, manifestation of HIV disease and improved the life expe
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S48-S52
Background: Pyomyositis is a bacterial infection of the large skeletal muscles presenting with muscle pain and swelling. It is commonly seen in the tropics but is being recognised more in end-stage HIV/AIDS. In HIV-associated pyomyositis, leukocytosi
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S15-S24
Background: Untreated HIV/AIDS leads to severe immune depletion with opportunistic infections and other co-morbidities. Highly active anti-retroviral therapy (HAART) enhances immunity by sustained HIV- viral suppression, increase in CD4+ cell count a
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S40-S47
Background: HIV Anti-retroviral therapy (ART) related liver injury (ARLI) isassociated with elevated liver transaminases (AST/ALT), potential liver failure and death. It is commonly associated with nevirapine. Identification of pre- clinical risk fac
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S83-S88
Background: Healthcare worker capacity building efforts over the past decade have resulted in decentralisation of HIV prevention, care and treatment servicesObjective: To provide an overview of the evolution of HIV training in Kenya, from 2003 to dat
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S79-S82
The World Health Organisation anti-retroviral treatment guidelines for resource limited settings rationalise the recommended standard first and second-line regimens on the basis of their efficacy, tolerability, toxicity, availability of fixed-dose co
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S57-S61
Background: Highly active anti-retroviral therapy (HAART) reduces morbidity and mortality in HIV/AIDS infected patients. HAART is used indefinitely and the regimens are changed over the course of treatment due to resistance, adverse drug reactions or
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S3-S14
Background: Sub-Saharan Africa with under 10% of the worldfs total population accounts for 60-70% of all HIV/AIDS cases. While these patients require HAART to manage the disease, HAART is not universally available. Majority of the patients are in r
Publikováno v:
East African Medical Journal; Vol 90, No 12 (2013): Supplement; S33-S39
Background: Cryptococcus meningitis is the most lethal meningitis in patients with HIV/AIDS. It is invariably fatal if not treated appropriately and promptly. In sub-Saharan Africa with the highest prevalence of HIV/AIDS, response to treatment of cry
Autor:
Ochieng PO; Department of Clinical Medicine and Therapeutics, College of Health Sciences, University of Nairobi, P. O. Box 19676-00202, Nairobi, Kenya., McLigeyo SO, Amayo EO, Kayima JK, Omonge EO
Publikováno v:
East African medical journal [East Afr Med J] 2009 Sep; Vol. 86 (9), pp. 435-41.